Yaqian Pan

Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC.

F. Ye, Zixin Xie, Xuebao. Wang, 2019, European journal of medicinal chemistry.

Design, synthesis and pharmacological evaluation of N4,N6-disubstituted pyrimidine-4,6-diamine derivatives as potent EGFR inhibitors in non-small cell lung cancer.

Yong Xu, F. Ye, Jinsan Zhang, 2018, European journal of medicinal chemistry.

MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.

Jun Liu, Yaqian Pan, Qiong Ouyang, 2016, International immunopharmacology.

Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer

F. Ye, Zixin Xie, Zhiguo Liu, 2018, Journal of enzyme inhibition and medicinal chemistry.